Resources for Healthcare Policy Makers and Policy Opinion Leaders

 

2018 Value and Innovation Report

Our 2018 Value and Innovation Report is the first-ever examination of the different ways in which Celgene’s pursuit of innovation creates value for patients, the health system, the economy and society, and future innovation. We will issue this report on an annual basis to track its progress using our value pillars.

Key Facts in Multiple Myeloma

Celgene innovation has played a key role in bringing forward significant advancements in outcomes for patients with multiple myeloma. The improvements in the understanding of the disease and patient outcomes are the result of considerable time and resources invested by Celgene over the years.
 



These reports are intended for U.S. government officials, other healthcare policy makers
and healthcare policy opinion leaders.